GATA3, GATA binding protein 3, 2625

N. diseases: 429; N. variants: 30
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004096
Disease: Asthma
Asthma
0.400 GeneticVariation disease GWASCAT Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study. 30552067 2019
CUI: C0004096
Disease: Asthma
Asthma
0.400 GeneticVariation disease GWASCAT Shared genetics of asthma and mental health disorders: a large-scale genome-wide cross-trait analysis. 31619474 2019
CUI: C0004096
Disease: Asthma
Asthma
0.400 Biomarker disease BEFREE However, the most recent genome-wide asthma severity association study, conducted in more than 57 000 individuals, demonstrated significant associations for 25 loci, including three not previously associated with asthma: GATA3, MUC5AC, and KIAA1109. 30896504 2019
CUI: C0004096
Disease: Asthma
Asthma
0.400 GeneticVariation disease GWASCAT Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct. 30929738 2019
CUI: C0004096
Disease: Asthma
Asthma
0.400 Biomarker disease BEFREE However, the most recent genome-wide asthma severity association study, conducted in more than 57 000 individuals, demonstrated significant associations for 25 loci, including three not previously associated with asthma: GATA3, MUC5AC, and KIAA1109. 31090575 2019
CUI: C0004096
Disease: Asthma
Asthma
0.400 Biomarker disease BEFREE Moreover, IL-17A/IL-10 and RORγt/Foxp3 ratios, but not IL-4/IFN-γ or GATA-3/T-bet ratios, negatively correlated with forced expiratory volume in the first second (FEV<sub>1</sub>)/FEV<sub>1pred</sub> and Asthma Control Test Questionnaire (ACT) scores in both exacerbation group and non-exacerbation group. 30233198 2018
CUI: C0004096
Disease: Asthma
Asthma
0.400 AlteredExpression disease BEFREE Airway hyperreactivity, leukocyte infiltration, tissue remodeling, and cytokine levels as well as phosphorylated GC receptor (p-GCR), p-GATA-3, p-p38, MAPK phosphatase-1 (MKP-1), and GC-induced leucine zipper (GILZ) levels were assessed. 29914889 2018
CUI: C0004096
Disease: Asthma
Asthma
0.400 Biomarker disease BEFREE With the exception of CD19+ cells and IL‑12p40, M. atichisonii affected almost all factors related to asthma induction including the T helper (Th)1/Th2 transcription factors, T‑bet and GATA‑3, Th1‑related cytokines, Th2‑related cytokines and proinflammatory cytokines. 29115454 2018
CUI: C0004096
Disease: Asthma
Asthma
0.400 AlteredExpression disease BEFREE Further, low-dose LPS (1 ug) exposure was associated with increased Th1 cytokines, T-bet, Treg cytokine (IL-10, TGF-β), and Foxp3 expression, but decreased Th2 cytokines (IL-4,5,13), GATA3, Th17, and ROR-gt expression compared with the asthma group. 29768397 2018
CUI: C0004096
Disease: Asthma
Asthma
0.400 AlteredExpression disease BEFREE DFSCs decreased IL-4 and GATA3 expression and increased IFN-γ, T-bet and IL-10 expression in asthmatics. 29498435 2018
CUI: C0004096
Disease: Asthma
Asthma
0.400 PosttranslationalModification disease BEFREE Furthermore, we demonstrated that the GATA3 CpG loci associated with later risk of asthma lie within a NF-κB binding site and that methylation here blocks transcription factor binding to the GATA3 promoter in the human Jurkat T-cell line. 28756630 2017
CUI: C0004096
Disease: Asthma
Asthma
0.400 Biomarker disease BEFREE STAT-6 and GATA-3 are reported to be central players in PARP-1-mediated eosinophilic inflammation in asthma. 28974953 2017
CUI: C0004096
Disease: Asthma
Asthma
0.400 AlteredExpression disease BEFREE Here, we summarize the development of a GATA-3-specific DNAzyme-a molecule class that combines the superior specificity of antisense molecules with an inherent RNA-cleaving enzymatic activity-for the treatment of type-2-driven asthma from preclinical development toward a proof-of-concept clinical study. 27910098 2017
CUI: C0004096
Disease: Asthma
Asthma
0.400 Biomarker disease BEFREE The results of the present study suggested that the therapeutic mechanism by which afzelin effectively treats asthma is based on reduction of Th2 cytokine via inhibition of GATA-binding protein 3 transcription factor, which is the master regulator of Th2 cytokine differentiation and production. 25738969 2015
CUI: C0004096
Disease: Asthma
Asthma
0.400 Biomarker disease BEFREE Previous studies have proved that ligustrazine can modulate the expression of transcription factors for Th1 (T-bet) and Th2 (Gata-3) in asthma. 24785327 2014
CUI: C0004096
Disease: Asthma
Asthma
0.400 Biomarker disease BEFREE In this review we will try to explore the link between IL-13 and GATA3 in the progression and regulation of asthma and its possible role as a therapeutic target. 24363163 2014
CUI: C0004096
Disease: Asthma
Asthma
0.400 AlteredExpression disease BEFREE Biopsy specimens from CRS patients without asthma were subjected to immunohistochemistry for detection of T-bet and GATA-3 expression in CD3+ T cells by double labeling. 24153332 2013
CUI: C0004096
Disease: Asthma
Asthma
0.400 AlteredExpression disease BEFREE However, the percent of Th2 cells, IL-4 levels and expression of GATA-3 mRNA was markedly higher in patients with mild and moderate to severe asthma than in the control group. 23786933 2013
CUI: C0004096
Disease: Asthma
Asthma
0.400 Biomarker disease BEFREE GATA binding protein 3 (GATA3) is a key molecule regulating the balance in the ratio of type 1 helper T (Th1) cells to type 2 helper T (Th2) cells, which is thought to be indicative of the pathogenesis of allergic diseases such as asthma and atopic dermatitis. 21537830 2011
CUI: C0004096
Disease: Asthma
Asthma
0.400 AlteredExpression disease BEFREE Major transcription factors controlling T(H)1 and T(H)2 development, such as T-box transcription factor and GATA3, might be centrally involved in asthma and atopic diseases. 19038437 2009
CUI: C0004096
Disease: Asthma
Asthma
0.400 Biomarker disease BEFREE We identified T cell transcription factors important for asthma - such as T-bet, c-maf, GATA-3. 18537589 2008
CUI: C0004096
Disease: Asthma
Asthma
0.400 Biomarker disease BEFREE We studied the silencing of the GATA-3 gene expression using RNA interference (RNAi) delivered by a lentiviral vector, to evaluate the therapeutic role of GATA-3 short hairpin RNAs (shRNAs) in a murine model of asthma. 17878900 2008
CUI: C0004096
Disease: Asthma
Asthma
0.400 Biomarker disease RGD Intraperitoneal ligustrazine administration could significantly lower the level of IL-4 in BALF and the expression of GATA-3 protein in lung and also increase the level of IFN-gamma and T-bet in asthmatic rats, resulting in a decreased percentage of eosinophils (EOS) in BALF and ameliorated airway inflammatory cell infiltration. 18186587 2007
CUI: C0004096
Disease: Asthma
Asthma
0.400 AlteredExpression disease BEFREE In bronchial biopsies, the basal expression of GATA-3 was increased in asthmatics compared to healthy controls but decreased after allergen challenge. 16498264 2006
CUI: C0004096
Disease: Asthma
Asthma
0.400 AlteredExpression disease BEFREE We report using p62-/- mice and cells that p62 acts downstream TCR activation, and is important for Th2 polarization and asthma, playing a significant role in the control of the sustained activation of NF-kappaB and late synthesis of GATA3 and IL-4 by participating in the activation of the IKK complex. 16874300 2006